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ABSTRACT 
Background Fish consumption and omega-3 polyunsaturated fatty acid (PUFA) intake are shown 
to protect from cardiovascular diseases (CVD). However, most fish contain environmental 
contaminants such as dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), polychlorinated biphenyls 
(PCBs), and methylmercury (MeHg) that may have adverse effects on cardiovascular health.  
Objective Our aim was to elucidate the associations of fish consumption, omega-3 PUFAs, 
environmental contaminants with low-grade inflammation, early atherosclerosis, and traditional 
CVD risk factors. 
Methods The Health 2000 survey participants (n=1173) represented the general Finnish population 
and the Fishermen study participants (n=255) represented a population with high fish consumption 
and high exposure to environmental contaminants. Model-adjusted geometric means and tests for 
linear trend were calculated for CVD risk factors by tertiles of fish consumption and serum omega-
3 PUFAs, and additionally in the Fishermen study only, by tertiles of serum PCDD/F+PCB, and 
blood MeHg.  
Results Serum triglyceride decreased across omega-3 PUFA tertiles in both sexes and studies. 
Insulin resistance, C-reactive protein, tumour necrosis factor α, and interleukin 6 decreased across 
omega-3 PUFA tertiles among the Health 2000 survey participants. Among the Fishermen study 
men, insulin resistance and arterial stiffness indicated by β-stiffness index tended to increase and 
the RR estimate for carotid artery plaque tended to decrease across tertiles of PCDD/F+PCB and 
MeHg.  
Conclusion Previously established hypotriglyceridemic and anti-inflammatory effects of omega-3 
PUFAs were seen also in this study. The hypothesised favourable effect on insulin sensitivity and 
arterial elasticity was suggested to be counteracted by high exposure to environmental contaminants 
but the effect on plaque prevalence appeared not to be harmful. 
Keywords: fish; omega-3; dioxin; PCB; methylmercury; inflammation; atherosclerosis 
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1. Introduction 
 
Many of the traditional risk factors for cardiovascular diseases (CVD) and diabetes, such as 
hypertension, dyslipidemia, and insulin resistance, are suspected to be favourably affected by high 
fish consumption and high intake of fish-derived long-chain omega-3 polyunsaturated fatty acids 
(PUFAs) (Calder and Yaqoob, 2009; Carpentier et al., 2006; Riediger et al., 2009). Further, omega-
3 PUFAs have been observed to decrease the production of pro-inflammatory eicosanoids and 
cytokines and thus, fish consumption is believed to protect from diseases involving inflammatory 
processes (Calder, 2006; Wall et al., 2010). Fish consumption and omega-3 PUFA intake have also 
been suggested to slow the progression of atherosclerosis (Massaro et al., 2008) and to reduce 
arterial stiffness (Hall, 2009).  
 
In contrast, most fish contain bioaccumulative environmental contaminants that have endocrine-
disrupting potency and may have an adverse effect on cardiovascular health (Bushkin-Bedient and 
Carpenter, 2010). For example, high exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the 
most toxic congener of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), is 
hypothesised to increase the risk of circulatory diseases and diabetes (Consonni et al., 2008). In 
addition, PCDD/Fs, polychlorinated biphenyls (PCBs), and methyl mercury (MeHg) are suspected 
to have a capacity to increase both blood pressure and oxidative stress, alter lipid, glucose and 
insulin metabolism, and promote inflammatory processes (Everett et al., 2011; Hennig et al., 2007; 
Mozaffarian, 2009). Especially exposure to PCBs has lately been linked with obesity, dyslipidemia, 
insulin resistance (Lee et al., 2011) and the risk of diabetes (Airaksinen et al., 2011).  
 
Although the benefits of fish consumption and omega-3 PUFAs have been extensively studied, 
some controversy still remains (Hooper et al., 2006; Salas-Salvado et al., 2011) and one explanation 
for conflicting findings might be competing effects of environmental contaminants in fish (He, 
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2009). More importantly, the benefits of fish consumption and omega-3 PUFA intake have rarely 
been studied in populations with high exposure to environmental contaminants. Our aim was to 
study the associations of habitual fish consumption and serum concentrations of fish-derived 
omega-3 PUFAs and environmental contaminants with chronic low-grade systemic inflammation, 
early signs of atherosclerosis, and traditional CVD risk factors taking into account the overall effect 
of beneficial and hazardous compounds in fish. We conducted the analyses in a sub-sample of the 
general Finnish population and among professional Baltic Sea area fishermen and their family 
members. The latter is a unique population with high fish consumption and high exposure to 
environmental contaminants.  
 6 
2. Methods 
 
2.1. Study populations 
 
The nationally representative Health 2000 health examination survey (the Health 2000 survey) was 
conducted in 2001–2002 (Heistaro, 2008). A total of 1526 volunteers, aged 45–74 years, and living 
near the five university hospitals (Helsinki, Turku, Tampere, Kuopio, and Oulu) participated in a 
cardiovascular and diabetes sub-study and of those, 532 men and 641 women had complete dietary, 
health interview, and basic health examination data for the present work. Further, of those, 406 men 
and 499 women had also ultrasound data for the analyses of vascular structure and function. 
 
The Nutrition, environment and health study (the Fishermen study) on professional Baltic Sea area 
fishermen, their wives, and other family members was conducted in 2004–2005 (Turunen et al., 
2008). A total of 309 volunteers, aged 22–74 years, and living near Helsinki and Turku study 
centres participated in a health examination study  and of those, 123 men and 132 women had 
complete dietary, health questionnaire, and basic health examination data for the present work. 
Further, of those, 84 men and 90 women had also ultrasound data for the analyses of vascular 
structure and function. 
 
Both studies were coordinated by the National Institute for Health and Welfare (THL) in Finland. 
The studies were conducted according to similar study protocols and the guidelines laid down in the 
Declaration of Helsinki and Uniform Requirements for manuscripts submitted to Biomedical 
journals. The study protocols were approved by the ethical committee of the Hospital District of 
Helsinki and Uusimaa, and a written informed consent was obtained from all participants.  
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2.2. Dietary data 
 
In both studies, diet was assessed by the same calibrated (i.e., determined to have relative validity) 
self-administered 128-item food frequency questionnaire (FFQ) designed to cover the whole diet 
and the use of dietary supplements (such as fish oil capsules) over the past 12 months (Männistö et 
al., 1996; Paalanen et al., 2006). Consumption of fish and other foods and the intakes of alcohol and 
salt (g/day) were calculated with the national Fineli

 Finnish Food Composition Database. Dietary 
data has been described in detail elsewhere (Turunen et al., 2010).  
 
 
2.3. Laboratory analyses 
 
Blood samples were drawn from antecubital vein after 10–12 hours of fasting. Serum 
concentrations of fatty acids were analysed using a gas chromatograph and flame ionisation detector 
(Jula et al., 2005). The sum of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and 
docosahexaenoic acid (DHA) (namely omega-3 PUFAs) was calculated as a proportion from all 
serum fatty acids (% FAs). 
 
Serum total cholesterol and triglyceride concentrations were analysed by spectrophotometric 
enzymatic method, high-density lipoprotein (HDL, mmol/l) cholesterol by a direct method, glucose 
(mmol/l) by hexokinase method, and insulin (mU/l) by microparticle enzyme immunoassay.  
Homeostasis model assessment (HOMA) indexes, namely insulin resistance index (HOMA-IR) and 
pancreatic β-cell function (HOMA-%B), were calculated using formulas listed in Appendix.     
 
Serum concentrations of highly sensitive C-reactive protein (CRP, mg/l), tumour necrosis factor α 
(TNF-α, ng/l), and interleukin 6 (IL-6, ng/l) were analysed using a solid-phase enzyme-labelled 
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chemiluminescent immunometric assay in the Health 2000 survey. In the Fishermen study, CRP 
was analysed immunoturbidimetrically. Participants with CRP<10 mg/l were included in the study. 
 
In the Fishermen study only, serum concentrations of 17 PCDD/F and 37 PCB congeners were 
analysed gravimetrically from serum fat using a high resolution mass spectrometer equipped with a 
gas chromatograph. The method has been described in detail elsewhere (Kiviranta et al., 2002). 
PCDD/Fs and PCBs were expressed as toxic equivalent quantity (TEq) recommended by the World 
Health Organization (WHO). The sum of PCDD/F-TEq and PCB-TEq (PCDD/F+PCB-TEq, pg/g 
fat) was calculated. Blood MeHg concentration (ng/ml) was analysed from whole blood using an 
isotope dilution-gas chromatograph/mass spectrometer (Airaksinen et al., 2010). Blood samples to 
analyse environmental contaminants were not available in the Health 2000 survey.  
 
 
2.4. Vascular measurements 
 
Intima media thickness (IMT, mm) and arterial diameter change according to pulse pressure (ADC, 
mm) were measured from the right common carotid artery (CCA) at the level of the carotid 
bifurcation by high-resolution B-mode ultrasound. The method has been described in detail 
elsewhere (Niiranen et al., 2007; Sipila et al., 2011). The presence of formed atherosclerotic plaques 
in the carotid artery, defined as a focal raised lesion of >1.5 mm in size in at least one of the images 
of the carotid bulb, was determined. Measures for arterial stiffness, namely carotid artery 
compliance (CAC, %/10 mmHg), Young's elastic modulus (YEM, kPa), and β-stiffness index (SI), 
were calculated based on ADC using formulas listed in Appendix. Participants with all six arterial 
diameter measurements (approximately 90% of those who had participated in vascular 
measurements) were included in the analyses concerning ultrasonographic variables. 
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2.5. Body composition, blood pressure and other basic health characteristics 
 
Body mass index (BMI) was calculated using measured weight and height. Blood pressure was 
measured three times from the right brachial artery by an electronic sphygmomanometer (OMRON 
HEM 722C/OMRON M4, Omron Corporation, Japan) in sitting position after a 10 minute rest. For 
the calculations of the vascular markers, blood pressure was measured again three times in supine 
position directly before the ultrasound examination. Data on smoking, physical activity, and the use 
of insulin, oral glucose lowering drugs, lipid modifying drugs (such as statins), and blood pressure 
lowering drugs were obtained from a structured interview and a self-administered health 
questionnaire in the Health 2000 survey and from the self-administered health questionnaire in the 
Fishermen study.  
 
 
2.6. Statistical analyses 
 
For the primary analyses (Tables 2–5), the participants were categorised into tertiles according to 
their non-transformed total fish consumption and serum omega-3 PUFAs, and additionally in the 
Fishermen study only, according to their serum PCDD/F+PCB-TEq and blood MeHg. Due to 
skewed variable distributions, all continuous variables except for age and blood pressure were 
transformed according to natural logarithm. After log transformations, the normality of the residuals 
was satisfactory. Each log-transformed risk factor or marker was treated as a response variable at a 
time, and their model-adjusted geometric means were calculated by the above mentioned tertiles 
using GLM procedure in the Statistical Analysis Systems (SAS) and tested for linear trend. Since 
the geometric means for the tertiles were not equally spaced, the coefficients for linear contrasts 
were produced by SAS/IML software. Adjusted risk ratio (RR) for the presence of atherosclerotic 
plaque in the carotid artery wall was calculated by the above mentioned tertiles using a Poisson 
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regression model with robust error variance and GENMOD procedure in SAS, and tested for linear 
trend.  
 
To assess the shape of the studied associations and to evaluate the reliability of the results especially 
in the Fishermen study, an additive model with thin-plate regression spline was applied in the 
multiple generalised cross-validation package (mgcv) for R Statistical Software (Wood, 2006). The 
additive model is a non-parametric extension of a linear model for Gaussian response, and it allows 
the data to “speak for themselves” because a smoothing function does not assume a rigid form for 
the dependence. Continuous (instead of categorised) fish consumption, serum omega-3 PUFAs, 
serum PCDD/F+PCB-TEq, and blood MeHg were treated as smoothed predictors. Scatter plots with 
regression curves and approximate 95% CIs for selected associations are presented in Figure 1.  
 
The geometric means, RRs, and regression splines were adjusted for age, smoking, physical 
activity, vegetable, fruit, berry, and oil consumption, salt and alcohol intake, and the use of insulin, 
blood glucose lowering drugs, lipid modifying agents, and antihypertensives. In addition, the means 
and RRs were adjusted for traditional CVD risk factors (BMI, non-HDL cholesterol, serum 
triglycerides, insulin resistance, and systolic blood pressure). Vascular markers were additionally 
adjusted for inflammatory markers. Potential negative confounding was controlled for by adjusting 
the means and RRs across omega-3 PUFA tertiles for environmental contaminants and geometric 
means and RRs across tertiles of environmental contaminants for omega-3 PUFAs. The covariates 
were chosen based on a common knowledge on cardiovascular risk factors. Vegetable, fruit, berry, 
and oil consumption were included in the models since they were positively associated with fish 
consumption based on our previous study (Turunen et al., 2011).  
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3. Results 
 
Compared with the Health 2000 survey men and women, the geometric means for fish consumption 
and serum omega-3 PUFAs were approximately 80% higher among the Fishermen study men and, 
respectively, 40% and 70% higher among the Fishermen study women (Table 1).  
 
In the Health 2000 survey, serum HDL cholesterol increased and serum triglyceride decreased in 
both sexes, and serum insulin and insulin resistance measured by HOMA-IR index decreased 
among the women across serum omega-3 PUFA tertiles (Table 2). Additionally among the women, 
BMI, waist circumference and pancreatic β-cell function measured by HOMA-%B index decreased 
across omega-3 PUFA tertiles. Regarding markers of inflammation and early atherosclerosis, serum 
TNF-α and IL-6 decreased across omega-3 PUFA tertiles in both sexes whereas serum CRP 
decreased across omega-3 PUFA tertiles only among the women. Arterial stiffness measured by β-
stiffness index decreased across omega-3 PUFA tertiles only among the men (Table 3). Overall, 
similar but weaker trends were seen across fish consumption tertiles. 
 
In the Fishermen study, many of the observed linear trends were statistically non-significant, and 
thus, they are referred here to as tendencies towards a linear trend. Serum triglyceride decreased 
across serum omega-3 PUFA tertiles among the men, and there was a tendency towards a 
decreasing trend among the women (Table 2). Among the men, serum CRP had a tendency to 
decrease across fish consumption tertiles (Table 2), and the RR estimate for atherosclerotic plaque 
in the carotid artery decreased across blood MeHg tertiles and had a tendency to decrease across 
tertiles of serum PCDD/F+PCB-TEq (Table 5). 
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Some unhealthy trends were also observed in the Fishermen study. Among the men, serum glucose, 
serum insulin, and HOMA-IR index had a tendency to increase especially across fish consumption, 
serum PCDD/F+PCB-TEq, and blood MeHg tertiles (Tables 3 and 5). Additionally, carotid artery 
compliance decreased and β-stiffness index increased across omega-3 PUFA, PCDD/F+PCB-TEq, 
and MeHg tertiles among the men (Tables 3 and 5). Among the women, serum glucose 
concentration increased across MeHg tertiles, HOMA-%B tended to decrease across 
PCDD/F+PCB-TEq tertiles, and serum CRP tended to increase across MeHg tertiles (Table 4).  
 
In both studies, all the above mentioned results stayed essentially the same after additional adjusting 
for traditional CVD risk factors (BMI, non-HDL cholesterol, serum triglycerides, insulin resistance, 
systolic blood pressure) and the use of fish oil supplements, and regarding vascular markers, also 
after additional adjusting for inflammatory markers (data not shown). The only detectable change 
was seen when the linear trends in serum insulin and insulin resistance slightly attenuated after 
adjusting for BMI. Furthermore, the observed trends especially in inflammatory markers among the 
Health 2000 survey men and in the RR estimate for carotid artery plaque among the Fishermen 
study men were attenuated when obese (BMI≥30) individuals were excluded. To control for 
negative confounding in the Fishermen study, means across omega-3 PUFA tertiles were 
additionally adjusted for environmental contaminants and vice versa but it did not change the 
results. 
 
The regression curves produced by the additive model gave reassurance that a linear trend test could 
be applied for the studied associations. In addition, the shapes of the curves supported the 
conclusions made based on the model-adjusted means. Increasing trends in insulin resistance and β-
stiffness index and a decreasing trend in the risk of carotid artery plaque across tertiles of 
environmental contaminants among the Fishermen study men are visualised in Figure 1.  
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4. Discussion 
 
In the Health 2000 survey, a beneficial decreasing trend along with increasing serum fish-derived 
omega-3 PUFA concentration was observed in serum triglyceride, inflammatory markers, insulin 
resistance measured by HOMA-IR index (only among the women), and arterial stiffness measured 
by β-stiffness index (only among the men). Except for serum triglyceride concentration, these 
beneficial trends were not clearly seen in the Fishermen study. On the contrary, an increasing trend 
in insulin resistance and arterial stiffness was observed along with increasing serum omega-3 
PUFAs and environmental contaminants among the men. However, the risk of atherosclerotic 
plaque in the carotid artery tended to decrease along with increasing contaminant concentrations. 
The results stayed essentially the same regardless of adjustments. 
 
 
4.1. Strengths and limitations 
 
We utilised two separate study populations of which the larger was a sub-sample of the general 
population of Finland with an exceptionally high response rate. The smaller was a unique 
population of professional Baltic Sea area fishermen and their family members. Among the men in 
this high-exposure population, fish consumption and serum concentrations omega-3 PUFAs and 
environmental contaminants were almost twofold when compared with the males representing the 
general population of Finland (Turunen et al., 2011; Turunen et al., 2008). Furthermore, the 
fishermen’s serum TCDD concentration was comparable to that measured among the residents in 
the second highest exposure zone B in Seveso Italy after the industrial accident (Pesatori et al., 
2009). The multidisciplinary data included several exposures and risk factors, and both omega-3 
PUFAs and environmental contaminants were simultaneously included into the models to control 
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for potential negative confounding. In addition to testing for linear trend, we decided to present 
model-adjusted means by tertiles to enable one to explore also possible non-linear associations. 
 
Due to cross-sectional setting, causality could not be established in the present work. Another 
limitation was the small size of the Fishermen study population which could, at least partially, 
explain why some of the hypothesised associations were not detectable or some of the apparent 
linear tendencies across tertiles did not reach statistical significance. However, the regression curves 
produced by the additive model supported the conclusions made based on the model-adjusted 
means suggesting that the results of the primary analyses were reliable. In addition, a decrease in 
serum triglyceride concentration across serum omega-3 PUFAs was observed also in the Fishermen 
study which gave reassurance that at least strong associations could be detectable. Another 
limitation is the lack of blood samples to analyse environmental contaminants from the general 
population. Additionally, data on cooking method was not available but it may not be a problem 
since according to unpublished data from the Fishermen study, the only heavily processed fish dish 
commonly used in Finland, fish fingers, consisted only 1% of the total fish consumption. Pan-frying 
was the most common single cooking method for fish consisting 25% of all used methods but 
cooking and oven-baking combined were as common as pan-frying.  
 
 
4.2. Methodology 
 
The analyses were performed separately for men and women due to potential metabolic and other 
differences between the sexes. Further, tertiles were considered the most appropriate due to the 
small size of the Fishermen study. Total fish consumption was preferred since the analyses 
conducted separately for fatty and lean fish consumption yielded similar results (data not shown). 
Similarly, total serum omega-3 PUFA concentration was preferred since there were only subtle 
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differences in the results when EPA and DHA were considered separately (data not shown). More 
specifically, trends in HDL cholesterol and IMT were more evident across EPA tertiles, and trends 
in blood pressure, serum glucose, and the risk of carotid artery plaque were more evident across 
DHA tertiles in the general population sub-sample (data not shown). Many of the trends observed 
across omega-3 PUFA tertiles were weaker or even non-existent across fish consumption tertiles 
which is expected since the FFQ measures long-term diet whereas serum concentrations are 
absolute measures and markers of short-term dietary intake.  
 
The studied associations were adjusted for various combinations of covariates, for example 
traditional CVD risk factors (BMI, non-HDL cholesterol, serum triglycerides, insulin resistance, 
and systolic blood pressure). Additionally in the Fishermen study, potential negative confounding 
(Choi et al., 2008) was controlled for by adjusting means across omega-3 PUFA tertiles for 
environmental contaminants and vice versa. However, the models were stable regardless of large 
number of covariates, and the adjustments did not essentially change the results. In addition, we 
entered fish consumption and omega-3 PUFAs simultaneously into the models. As a result, models 
remained stable and the estimates for omega-3 PUFAs remained essentially the same. However, 
when studying the association between fish consumption and cardiovascular risk factors, adjusting 
for omega-3 PUFAs attenuated some of the observed trends especially in serum triglyceride 
concentration. 
 
In multiple regression modelling, over-adjustment and multicollinearity are potential problems. For 
example, BMI is probably an intermediate variable in the causal pathway of many of the studied 
associations in the present work. Thus, BMI and other traditional CVD risk factors were omitted 
from the reported model. Regarding multicollinearity, energy intake caused multicollinearity with 
food consumption variables and thus, it was not included in the models. Otherwise, 
multicollinearity was not a problem based on pairwise Pearson correlation coefficients between the 
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covariates (commonly around 0.2 and, at the highest, 0.6–0.7 between oil and salt intake) and the 
collinearity diagnostics (e.g., condition index).  
 
 
4.3. Insulin sensitivity 
 
Intervention studies among healthy individuals (Damsgaard et al., 2008; Giacco et al., 2007; Lara et 
al., 2007; Rizza et al., 2009) and many cohort studies (Dewailly et al., 2002; Lee et al., 2008; Nogi 
et al., 2007) have seen no association between fish consumption or omega-3 PUFA intake and 
glucose and insulin metabolism. Intervention studies among high-risk individuals have yielded 
inconsistent results. For example, among diabetics, both a decrease (Mostad et al., 2006) and an 
increase (Karlstrom et al., 2011) in insulin sensitivity have been observed. In addition, an increase 
has also been observed among obese individuals (Ramel et al., 2008) which implies that  the 
beneficial effect might be best observable among individuals with metabolic syndrome (Nigam et 
al., 2009). The fact that metabolic syndrome and diabetes are common in Finland could explain why 
beneficial inverse association between fish consumption or serum omega-3 PUFAs and insulin 
resistance measured by HOMA-IR was observed among women in the Health 2000 survey. 
  
With regard to unhealthy effects, serum insulin concentration and insulin resistance tended to 
increase along with increasing serum PCDD/F+PCB-TEq and blood MeHg concentrations among 
the men in the Fishermen study. This contradictory result could be, at least partly explained by 
environmental contaminants since a similar adverse trend has been observed previously among the 
Inuit (Ebbesson et al., 2007) who are known to eat a lot of potentially contaminated marine 
mammals and fish. Regarding non-dietary exposure, an increasing insulin resistance has been 
observed among residents near a closed pentachlorophenol and chlor-alkali factory along with 
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increasing serum PCDD/F and blood mercury concentrations (Chang et al., 2010) and among 
Vietnam veterans (Kern et al., 2004) along with increasing serum TCDD concentration. 
 
Additionally in the present work, a tendency towards a decreasing pancreatic β-cell function 
measured by HOMA-%B was observed along with increasing fish consumption and serum omega-3 
PUFAs among the women in the Health 2000 survey and along with increasing serum 
PCDD/F+PCB-TEq among the women in the Fishermen study. A similar inverse association 
between β-cell function and dioxin-like and non-dioxin-like PCBs has been observed among the 
Greenland Inuit (Jorgensen et al., 2008) who have even higher serum concentrations of omega-3 
PUFAs (Thorseng et al., 2009) and environmental contaminants (Bjerregaard et al., 2001; Jorgensen 
et al., 2008) than in the present work. Regarding the women in the Fishermen study, a weak 
decreasing trend could be explained by relatively high exposure to environmental contaminants. In 
contrast, exposure to environmental contaminants was presumably lower among the women in the 
Health 2000 survey. This was inferred from their lower fish consumption when compared with the 
Fishermen study women and the fact that in Finland, approximately 95% of dioxin exposure and 
80% of PCB exposure originates from fish (Kiviranta et al., 2004). A decrease in their β-cell 
function could be a compensation after a decrease in serum insulin and an increase in insulin 
sensitivity along with increasing fish consumption and omega-3 PUFA intake. 
 
 
4.4. Low-grade systemic inflammation 
 
An inverse association between fish consumption or omega-3 PUFA intake and inflammatory 
markers have been observed in the majority of the previous studies on the topic (Farzaneh-Far et al., 
2009; Ferrucci et al., 2006; He et al., 2009; Kalogeropoulos et al., 2010; Ohsawa et al., 2008). In the 
present work, the inverse association was strong in the Health 2000 survey especially regarding 
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TNF-α and IL-6. An absence of a clear beneficial association in the Fishermen study could be due 
to chance or possibly the exposure to environmental contaminants was high enough to attenuate or 
even cancel out the anti-inflammatory effect. On the other hand, since fish consumption and serum 
omega-3 PUFA concentrations were relatively high among the Fishermen study participants, a 
beneficial effect might have reached a plateau and would no longer be detectable. Furthermore, the 
anti-inflammatory effect of omega-3 PUFAs might be best observable among high-risk individuals 
(Ohsawa et al., 2008). 
 
 
4.5. Early signs of atherosclerosis 
 
In some of the previous intervention studies, omega-3 PUFA supplementation has increased arterial 
elasticity (Nestel et al., 2002; Sjoberg et al., 2010; Wang et al., 2008). Similarly in the present work, 
arterial stiffness decreased along with increasing serum omega-3 PUFAs among the men in Health 
2000 survey. In contrast, an increase in arterial stiffness measured by β-stiffness index along with 
increasing contaminant concentrations was observed among the men in the Fishermen study. This 
contradictory finding is indirectly supported by several previous observational studies where serum 
PCDD/Fs, serum PCBs, and blood mercury were associated with elevated blood pressure (Chang et 
al., 2011; Goncharov et al., 2011; Uemura et al., 2009; Valera et al., 2009) which is strongly 
associated with arterial stiffness. In the present work, there was a tendency towards increasing 
blood pressure among the men with high fish consumption and in addition, fish consumption was 
positively correlated with sodium chloride intake (Spearman correlation coefficient around 0.4). 
Thus, fish-related sodium chloride intake together with high exposure to environmental 
contaminants and their consequent effect on blood pressure could, at least partially, explain the 
observed increase in arterial stiffness.  
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Several observational studies among healthy individuals have reported an inverse association 
between fish consumption or serum omega-3 PUFAs and IMT (Ebbesson et al., 2008; Sala-Vila et 
al., 2010) or the prevalence of atherosclerotic plaque in the coronary artery (He et al., 2008; Heine-
Broring et al., 2010). In the present work, the risk of carotid artery plaque tended to decrease across 
tertiles of environmental contaminants among the men in the Fishermen study. This observation 
implies that despite the potential adverse effects on insulin sensitivity and arterial elasticity, high 
exposure to environmental contaminants may not be able to cancel out the beneficial effect of 
omega-3 PUFAs on the plaque formation and the overall effect remains beneficial. Regarding the 
RR estimates, however, it should be noted that the number of cases was probably underestimated 
since ultrasonography was performed only from one segment of the right common carotid artery. 
 
 
4.6. Conclusion 
 
Overall, the results of this cross-sectional study contribute to the growing body of evidence that the 
hypotriglyceridemic and anti-inflammatory effects of fish-derived omega-3 PUFAs have a pivotal 
role in the cardiovascular benefits of fish consumption. Other beneficial trends were seen in 
glucose-insulin metabolism and arterial stiffness. Our results also suggest that high dietary exposure 
to fish-derived environmental contaminants might decrease insulin sensitivity and arterial elasticity 
assuming that the exposure is high enough to cancel out the beneficial effect of omega-3 PUFAs. At 
the same time, the overall effect on carotid artery plaque formation appeared not to be harmful 
regardless of high exposure to environmental contaminants.  
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Table 1. Characteristics of the study participants: unadjusted geometric means and their 95% confidence 
intervals (CI) for continuous variables or number of participants (n) and percentages (%) for categorical 
variables 
 
Health 2000 sub-study  Fishermen sub-study 
 Men (n=532)  Women (n=641)  Men (n=123)  Women (n=132) 
 Mean 95% CI  Mean 95% CI  Mean 95% CI  Mean 95% CI 
Dietary data
a
            
Fish consumption, g/day 35 33–38  36 34–38  64 56–72  50 45–56 
Vegetable consumption, g/day 189 178–201  256 244–268  169 150–189  255 230–282 
Fruit and berry consumption, g/day 114 103–126  186 173–201  139 119–162  180 150–216 
Oil consumption, g/day 7.7 7.4–8.1  7.3 7.1–7.6  8.2 7.6–8.9  7.7 7.2–8.3 
Alcohol intake, g/day  4.5 4.1–5.0  1.8 1.7–2.0  7.2 5.9–8.6  2.6 2.1–3.2 
Salt intake, g/day 11 10–11  9.9 9.6–10  9.6 9.1–10  8.5 8.1–8.9 
Serum omega-3 PUFAs
b
, % serum FAs 3.6 3.5–3.8  3.7 3.6–3.8  6.3 5.8–6.8  6.4 6.0–6.8 
Environmental contaminants            
Serum PCDD/F+PCB-TEq
 c
, pg/g fat - -  - -  98 84–114  54 47–62 
Blood MeHg, ng/ml - -  - -  3.8 3.2–4.4  2.3 2.0–2.6 
Traditional risk factors            
Age, years  57 57–58  58 57–58  52 50–54  48 46–50 
Smoking, n (%)             
Never smoker 191 (36)  413 (64)  50 (41)  86 (65) 
Occasional or former smoker
d
 222 (42)  131 (21)  46 (37)  29 (22) 
Daily smoker 119 (22)  97 (15)  27 (22)  17 (13) 
Physical activity, n (%)            
Sufficient 199 (37)  246 (38)  37 (30)  41 (31) 
Intermediate
e
 147 (28)  190 (30)  33 (27)  42 (32) 
Sedentary 186 (35)  205 (32)  53 (43)  49 (37) 
BMI, kg/m
2
 27 27–28  26 26–27  27 27–28  26 25–27 
Waist circumference, cm 99 98–100  87 86–88  98 96–100  85 83–87 
Systolic blood pressure, mmHg 140 139–142  134 
 
132–135  134 131–137  122 119–126 
Diastolic blood pressure, mmHg 87 86–88  81 81–82  85 83–86  78 77–80 
Serum HDL cholesterol, mmol/l 1.4 1.4–1.4  1.7 1.6–1.7  1.5 1.4–1.6  1.7 1.6–1.7 
Serum non-HDL cholesterol, mmol/l 4.0 3.9–4.0  3.8 3.7–3.9  4.1 4.0–4.3  3.6 3.4–3.8 
Serum triglycerides, mmol/l 1.3 1.3–1.4  1.1 1.1–1.2  1.2 1.1–1.3  1.0 0.97–1.1 
Serum glucose, mmol/l 6.0 5.9–6.1  5.5 5.5–5.6  5.7 5.5–5.8  5.3 5.2–5.3 
Serum insulin, mU/l 8.9 8.5–9.3  7.6 7.3–7.9  6.0 5.4–6.7  5.9 5.3–6.6 
HOMA-IR index
f
 2.4 2.2–2.5  1.9 1.8–1.9  1.5 1.3–1.7  1.4 1.2–1.5 
HOMA-%B index
g
 74 71–77  77 75–80  57 52–62  69 63–76 
Inflammatory markers  
 
  
 
  
 
  
 
Serum CRP, mg/l 1.5 1.4–1.6  1.4 1.3–1.5  1.3 1.1–1.5  1.3 1.1–1.6 
Serum TNF-α, ng/l 5.6 5.5–5.8  5.3 5.2–5.5  - -  - - 
Serum IL-6, ng/l 1.6 1.5–1.7  1.4 1.3–1.5  - -  - - 
Vascular markers
h
            
Carotid artery IMT
gi 
 0.82 0.80–0.83  0.77 0.76–0.78  0.80 0.76–0.84  0.74 0.71–0.77 
Plaque in carotid artery
j
, n (%) 69 (17)  54 (11)  22 (26)  13 (15) 
Carotid artery stiffness            
Compliance
k
, %/10 mmHg
 
0.80 0.76–0.84  0.84 0.80–0.88  0.79 0.68–0.92  0.95 0.86–1.1 
Elastic modulus
l
, kPa 830 788–874  741 707–777  796 683–928  624 565–689 
β-stiffness indexm 3.6 3.6–3.6  3.6 3.6–3.6  3.6 3.5–3.7  3.5 3.4–3.6 
Medications, n (%) of users            
Insulin 
 
9 (1.7)
n
  5 (0.78)
 n
  5 (4.1)  3 (2.3) 
Oral glucose lowering drugs 23 (4.3)
o
  12 (1.9)
o
  6 (4.9)  3 (2.3) 
Lipid modifying drugs 73 (14)
p
  67 (10)
p
  22 (18)  16 (12) 
Blood pressure lowering drugs 119 (22)
q
  145 (23)
q
  23 (19)  20 (15) 
Abbreviations: ATC, anatomical therapeutic chemical; BMI, body mass index; CRP, C-reactive protein; FA, 
fatty acid; HDL, high density lipoprotein; HOMA, homeostasis model assessment; IMT, intima-media 
thickness; IR, insulin resistance; IL-6, interleukin 6; MeHg, methyl mercury; PCB, polychlorinated biphenyl; 
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PCDD/F, polychlorinated dibenzo-p-dioxin and dibenzofuran; PUFA, polyunsaturated fatty acid; TEq, toxic 
equivalent quantity; TNF-α, tumour necrosis factor α 
a
 based on a food frequency questionnaire
  
b
 the sum of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) 
c
 the sum of World Health Organization’s toxic equivalent quantities for dioxins and PCBs 
d
 smoked two days ago at the minimum but within previous 10 years 
e
 mildly exhausting physical activity on free-time (duration at least 20 minutes) at least 2–3 times/week and 
physical activity while commuting (duration less than 30 minutes) daily
 
f
 insulin resistance index 
g
 pancreatic beta cell function 
h
 Health 2000 sub-study: men n=406, women n=499; Fishermen sub-study: men n=84, women n=90  
i 
three end-diastole images from lateral interrogation angle at least 1 cm away from the origin of the bulb 
j 
the prevalence of a focal raised lesion of >1.5 mm in size in at least one of the images of the carotid bulb 
k 
ability of the artery to expand according to pulse pressure 
l
 arterial stiffness independent of arterial wall thickness
 
m 
arterial stiffness relatively independent of blood pressure
 
n
 ATC code A10A 
o 
ATC code A10B 
p 
ATC code C10A 
q 
ATC codes C02–C09 
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Table 2. Model-adjusted* geometric means for traditional CVD risk factors and inflammatory markers by tertiles of fish consumption and serum omega-3 
PUFAs in the Health 2000 sub-study and the Fishermen sub-study.  
 Health 2000 sub-study 
 
Fishermen sub-study 
 Men (n=532)  Women (n=641)  Men (n=123)  Women (n=132) 
 1
st
  
tertile
a 
 
2
nd
  
tertile
b
  
3
rd
  
tertile
c
 
p
 
for  
linear 
trend 
 1
st
  
tertile
a 
 
2
nd
  
tertile
b
  
3
rd
  
tertile
c
 
p
 
for  
linear 
trend 
 
1
st
  
tertile
d 
 
2
nd
  
tertile
e
  
3
rd
  
tertile
f
 
p
 
for  
linear 
trend 
 
1
st
  
tertile
d 
 
2
nd
  
tertile
e
  
3
rd
  
tertile
f
 
p
 
for  
linear 
trend 
 Fish consumption, g/day 
Traditional risk factors                   
BMI, kg/m
2
 26.9 27.2 27.5 0.22  26.7 26.0 26.4 0.66  27.0 27.1 28.3 0.15  25.5 26.7 26.7 0.33 
Waist, cm 98.2 98.5 99.5 0.31  88.3 86.7 86.9 0.33  95.7 96.9 100 0.07  82.7 86.9 86.0 0.25 
Systolic BP, mmHg 143 142 140 0.26  138 134 134 0.07  130 137 137 0.22  121 123 127 0.15 
Diastolic BP, mmHg 89 87 86 0.02  82 82 82 0.50  83 88 85 0.52  77 79 81 0.11 
HDL, mmol/l 1.41 1.42 1.34 0.10  1.63 1.67 1.74 0.02  1.50 1.54 1.42 0.27  1.64 1.65 1.66 0.82 
Non-HDL, mmol/l 4.01 3.97 3.93 0.47  3.92 3.77 3.74 0.11  4.12 4.10 4.24 0.62  3.49 3.65 3.57 0.80 
Triglycerides, mmol/l 1.34 1.29 1.32 0.91  1.23 1.10 1.05 <0.01  1.27 1.11 1.15 0.54  1.03 1.00 1.09 0.51 
Glucose, mmol/l 5.94 6.05 5.99 0.67  5.53 5.52 5.54 0.92  5.49 5.75 5.81 0.09  5.25 5.28 5.24 0.89 
Insulin, mU/l 8.44 9.08 9.22 0.17  8.22 7.44 7.11 <0.01  5.58 5.62 6.89 0.12  5.76 6.56 5.47 0.60 
HOMA-IR index 2.23 2.44 2.45 0.19  2.02 1.82 1.75 0.01  1.36 1.44 1.78 0.08  1.34 1.54 1.27 0.62 
HOMA-%B index 71.8 73.8 76.3 0.29  82.5 76.2 73.3 0.01  57.2 51.5 62.2 0.38  67.3 76.2 64.8 0.63 
Inflammatory markers 
                  
CRP, mg/l 1.53 1.48 1.54 0.93  1.50 1.36 1.31 0.24  1.41 1.27 1.14 0.36  1.41 1.12 1.47 0.75 
TNF-α, ng/l 5.89 5.60 5.40 0.05  5.49 5.23 5.29 0.41  - - - -  - - - - 
IL-6, ng/l 1.67 1.62 1.57 0.48  1.46 1.33 1.41 0.77  - - - -  - - - - 
 Serum omega-3 PUFA concentration, % FAs 
Traditional risk factors                   
BMI, kg/m
2
 27.0 27.5 27.0 0.67  27.2 26.2 25.7 <0.01  26.5 27.8 28.1 0.10  25.9 25.6 27.5 0.11 
Waist, cm 
circumference, cm 
99.0 99.6 97.7 0.18  89.7 86.7 85.5 <0.01  94.3 98.6 100 0.03  84.3 84.4 86.9 0.28 
Systolic BP, mmHg 142 143 141 0.53  137 135 134 0.08  131 138 135 0.43  123 121 127 0.33 
Diastolic BP, mmHg 89 87 87 0.14  82 82 82 0.64  83 87 85 0.63  79 79 79 0.92 
HDL, mmol/l 1.34 1.36 1.46 <0.01  1.58 1.67 1.80 <0.01  1.51 1.49 1.46 0.57  1.64 1.71 1.60 0.60 
Non-HDL, mmol/l 4.01 3.91 3.98 0.85  3.94 3.74 3.76 0.08  4.18 4.18 4.09 0.71  3.50 3.75 3.47 0.79 
Triglycerides, mmol/l 1.45 1.33 1.17 <0.01  1.28 1.10 1.00 <0.01  1.32 1.26 0.97 0.01  1.10 1.06 0.96 0.13 
Glucose, mmol/l 6.00 6.05 5.93 0.33  5.56 5.50 5.52 0.61  5.62 5.69 5.74 0.51  5.22 5.16 5.40 0.07 
Insulin, mU/l 8.98 9.58 8.21 0.05  8.14 7.65 6.97 <0.01  5.74 5.79 6.48 0.36  5.87 5.43 6.49 0.39 
HOMA-IR index 2.40 2.57 2.17 0.05  2.01 1.87 1.71 <0.01  1.43 1.46 1.65 0.34  1.36 1.24 1.55 0.29 
HOMA-%B index 74.3 78.2 69.6 0.12  81.7 78.7 71.7 <0.01  55.2 54.8 60.3 0.44  70.2 66.8 70.9 0.88 
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Inflammatory markers 
        
 
         
CRP, mg/l 1.57 1.57 1.42 0.26  1.59 1.32 1.28 0.03  1.22 1.38 1.22 0.91  1.12 1.61 1.29 0.68 
TNF-α, ng/l 5.81 5.73 5.35 0.03  5.74 5.46 4.84 <0.01  - - - -  - - - - 
IL-6, ng/l 1.76 1.72 1.40 <0.01  1.57 1.45 1.20 <0.01  - - - -  - - - - 
* Adjusted for age, smoking, physical activity, vegetable, fruit, berry, and oil consumption, salt and alcohol intake, and the use of insulin, blood glucose lowering 
drugs, lipid modifying agents, and antihypertensives 
Abbreviations: BMI, body mass index; CRP, C-reactive protein; FA, fatty acid; HDL, high density lipoprotein; HOMA, homeostasis model assessment; IR, insulin 
resistance; IL-6, interleukin 6; PUFA, polyunsaturated fatty acid; TNF-α, tumour necrosis factor α 
 
Fish consumption, g/day: 
a
 men: n=177, mean=14, range 0–30; women: n=213, mean=16, range 0–31 
b
 men: n=178, mean=39, range 31–50; women: n=214, mean=38, range 32–47 
c
 men: n=177, mean=77, range 51–276; women: n=214, mean=71, range 48–417 
d
 men: n=41, mean=31, range 3.9–47; women: n=44, mean=26, range 0.54–41 
e
 men: n=42, mean=65, range 48–89; women: n=44, mean=52, range 42–67 
f
 men: n=40, mean=131, range 90–463; women: n=44, mean=93, range 68–282 
 
Serum omega-3 PUFA concentration, % FAs: 
a
 men: n=177, mean=2.4, range 1.0–3.0; women: n=213, mean=2.4, range 0.72–3.1 
b
 men: n=177, mean=3.5, range 3.1–4.3; women: n=216, mean=3.7, range 3.2–4.3 
c
 men: n=178, mean=5.7, range 4.4–12; women: n=212, mean=5.6, range 4.4–12 
d
 men: n=41, mean=4.1, range 2.6–5.0; women: n=44, mean=4.4, range 3.2–5.5 
e
 men: n=41, mean=6.1, range 5.1–7.4; women: n=44, mean=6.4, range 5.6–7.5 
f
 men: n=41, mean=10, range 7.5–23; women: n=44, mean=9.4, range 7.6–23 
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Table 3. Model-adjusted* geometric means for vascular markers and a risk ratio (RRs) for the presence of carotid artery plaque by tertiles of fish consumption 
and serum omega-3 PUFAs in the Health 2000 sub-study and the Fishermen sub-study.  
 Health 2000 sub-study  
 
Fishermen sub-study  
 Men (n=406)  Women (n=499)  Men (n=84) 
 Women (n=90) 
 1
st
  
tertile
a 
 
2
nd
  
tertile
b
  
3
rd
  
tertile
c
 
p
 
for  
linear 
trend 
 1
st
  
tertile
a 
 
2
nd
  
tertile
b
  
3
rd
  
tertile
c
 
p
 
for  
linear 
trend 
 
1
st
  
tertile
d 
 
2
nd
  
tertile
e
  
3
rd
  
tertile
f 
 
p
 
for  
linear 
trend 
 
1
st
  
tertile
d 
 
2
nd
  
tertile
e
  
3
rd
  
tertile
f
 
p
 
for  
linear 
trend 
 Fish consumption, g/day 
Vascular markers 
    
 
    
 
    
 
    
IMT (mm) 0.81 0.81 0.80 0.48  0.77 0.77 0.76 0.32  0.78 0.81 0.80 0.90  0.72 0.72 0.77 0.15 
Compliance (%/10 mmHg) 0.79 0.76 0.84 0.29  0.83 0.87 0.85 0.80  0.88 0.69 0.81 0.90  0.96 0.91 0.99 0.75 
Elastic modulus (kPa) 844 856 792 0.36  746 701 738 0.93  720 903 777 0.89  647 668 562 0.24 
β-stiffness index 3.61 3.66 3.55 0.32  3.60 3.58 3.60 0.92  3.56 3.66 3.60 0.88  3.50 3.57 3.49 0.84 
RR for plaque 1.00 0.82 1.09 0.71  1.00 0.49 0.54 0.11  1.00 3.06 1.70 0.55  1.00 1.38 1.00 0.96 
 Serum omega-3 PUFA concentration, % fatty acids 
Vascular markers 
    
 
    
          
IMT (mm) 0.81 0.81 0.81 0.79  0.78 0.76 0.76 0.20  0.79 0.81 0.79 0.82  0.72 0.74 0.75 0.40 
Compliance (%/10 mmHg) 0.76 0.75 0.89 0.01  0.85 0.83 0.88 0.40  1.07 0.72 0.65 0.03  1.01 0.97 0.88 0.25 
Elastic modulus (kPa) 866 889 743 0.01  728 750 708 0.56  597 870 971 0.04  592 617 665 0.36 
β-stiffness index 3.67 3.63 3.52 0.01  3.58 3.63 3.57 0.71  3.42 3.63 3.78 0.04  3.50 3.51 3.56 0.58 
RR for plaque 1.00 0.81 0.71 0.20  1.00 1.19 1.06 0.92  1.00 1.12 0.64 0.44  1.00 1.26 3.03 0.05 
* Adjusted for age, smoking, physical activity, vegetable, fruit, berry, and oil consumption, salt and alcohol intake, and the use of insulin, blood glucose lowering 
drugs, lipid modifying agents, and antihypertensives 
Abbreviations: FA, fatty acid; IMT, intima-media thickness; PUFA, polyunsaturated fatty acid; RR, risk ratio 
 
Fish consumption, g/day: 
a 
men: n=135, mean=14, range 0–30; women: n=166, mean=16, range 0–31 
b 
men: n=136, mean=38, range 31–49; women: n=167, mean=38, range 32–46 
c 
men: n=135, mean=76, range 50–276; women: n=166, mean=67, range 47–417 
d
 men: n=28, mean=32, range 3.9–47; women: n=30, mean=23, range 0.54–38 
e
 men: n=28, mean=61, range 48–77; women: n=30, mean=52, range 39–67 
f
 men: n=28, mean=143, range 78–463; women: n=30, mean=93, range 68–282 
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Serum omega-3 PUFA concentration, % FAs: 
a
 men: n=135, mean=2.4, range 1.0–3.1; women: n=167, mean=2.4, range 0.72–3.1 
b
 men: n=136, mean=3.6, range 3.2–4.4; women: n=165, mean=3.7, range 3.2–4.3 
c
 men: n=135, mean=5.7, range 4.5–12; women: n=167, mean=5.6, range 4.4–12 
d
 men: n=28, mean=3.9, range 2.6–5.0; women: n=30, mean=4.4, range 3.2–5.6 
e
 men: n=28, mean=6.1, range 5.1–7.7; women: n=30, mean=6.6, range 5.7–7.9 
f
 men: n=28, mean=9.8, range 7.8–23; women: n=30, mean=9.9, range 8.0–23 
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Table 4. Model-adjusted* geometric means for traditional CVD risk factors and CRP by tertiles of 
environmental contaminants in the Fishermen sub-study.  
 
 
Fishermen sub-study  
 Men (n=123)  Women (n=132) 
 1
st
  
tertile
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2
nd
  
tertile
b
  
3
rd
  
tertile
c
 
p
 
for  
linear 
trend 
 1
st
  
tertile
a 
 
2
nd
  
tertile
b
  
3
rd
  
tertile
c
 
p
 
for  
linear 
trend 
 Serum PCDD/F+PCB-TEq
 
concentration, pg/g fat 
Traditional risk factors          
BMI, kg/m
2
 26.4 27.9 28.1 0.18  26.5 25.9 26.5 0.91 
Waist, cm 95.5 99.7 97.7 0.60  86.5 84.4 84.8 0.66 
Systolic BP, mmHg 131 142 131 0.67  121 123 128 0.10 
Diastolic BP, mmHg 83 89 83 0.52  76 80 80 0.14 
HDL, mmol/l 1.54 1.47 1.44 0.34  1.68 1.56 1.73 0.42 
Non-HDL, mmol/l 4.34 4.06 4.06 0.39  3.79 3.45 3.48 0.41 
Triglycerides, mmol/l 1.21 1.21 1.10 0.45  1.14 1.01 0.97 0.19 
Glucose, mmol/l 5.61 5.72 5.72 0.62  5.17 5.32 5.28 0.49 
Insulin, mU/l 5.19 6.06 6.85 0.07  6.23 6.06 5.47 0.39 
HOMA-IR index 1.30 1.54 1.74 0.09  1.43 1.43 1.28 0.49 
HOMA-%B index 50.2 57.6 63.2 0.10  77.1 68.2 63.2 0.17 
CRP, mg/l  1.30 1.48 1.07 0.29  1.50 1.09 1.42 0.94 
          
 Blood MeHg concentration, ng/ml 
Traditional risk factors          
BMI, kg/m
2
 26.8 27.6 28.0 0.26  25.9 25.9 27.2 0.17 
Waist, cm 95.1 98.1 99.6 0.10  83.9 84.0 88.0 0.08 
Systolic BP, mmHg 135 133 136 0.79  124 121 127 0.30 
Diastolic BP, mmHg 85 85 86 0.67  78 78 80 0.30 
HDL, mmol/l 1.45 1.51 1.50 0.67  1.64 1.69 1.62 0.73 
Non-HDL, mmol/l 4.42 4.00 4.04 0.26  3.49 3.58 3.64 0.57 
Triglycerides, mmol/l 1.22 1.10 1.21 0.86  1.08 1.00 1.03 0.77 
Glucose, mmol/l 5.47 5.72 5.86 0.04  5.24 5.13 5.41 0.04 
Insulin, mU/l 5.60 5.72 6.75 0.15  6.24 5.06 6.56 0.42 
HOMA-IR index 1.36 1.46 1.76 0.09  1.45 1.16 1.58 0.30 
HOMA-%B index 58.5 52.9 59.1 0.75  73.3 63.5 71.2 0.97 
CRP, mg/l  1.46 1.11 1.28 0.75  0.96 1.56 1.59 0.07 
* Adjusted for age, smoking, physical activity, vegetable, fruit, berry, and oil consumption, salt and alcohol 
intake, and the use of insulin, blood glucose lowering drugs, lipid modifying agents, and antihypertensives 
Abbreviations: BMI, body mass index; CRP, C-reactive protein; HDL, high density lipoprotein; HOMA, 
homeostasis model assessment; IR, insulin resistance; IL-6, interleukin 6; MeHg, methylmercury; PCB, 
polychlorinated biphenyl; PCDD/F, polychlorinated dibenzo-p-dioxin and dibenzofuran; TEq, toxic equivalent 
quantity 
 
Serum PCDD/F+PCB-TEq
 
concentration, pg/g fat: 
a
 men: n=41, mean=37, range 6.6–69; women: n=44, mean=22, range 7.3–36 
b
 men: n=41, mean=106, range 70–155; women: n=44, mean=54, range 37–74 
c
 men: n=41, mean=239, range 156–590; women: n=44, mean=128, range 75–433 
 
Blood MeHg concentration, ng/ml: 
a
 men: n=41, mean=1.3, range 0.21–2.6; women: n=46, mean=0.96, range 0–1.5 
b
 men: n=42, mean=3.5, range 2.7–5.3; women: n=44, mean=2.2, range 1.6–2.9 
c
 men: n=40, mean=9.4, range 5.4–60; women: n=42, mean=5.0, range 3.0–20 
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Table 5. Model-adjusted* geometric means for vascular markers and a risk ratio (RRs) for the presence of 
carotid artery plaque by tertiles of environmental contaminants in the Fishermen study.  
 
 
Fishermen sub-study  
 Men (n=84)  Women (n=90) 
 1
st
  
tertile
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2
nd
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b
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p
 
for  
linear 
trend 
 1
st
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3
rd
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c
 
p
 
for  
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 Serum PCDD/F+PCB-TEq
 
concentration, pg/g fat 
Vascular markers          
IMT (mm) 0.82 0.78 0.79 0.66  0.74 0.74 0.73 0.62 
Compliance (%/10 mmHg) 1.05 0.70 0.68 0.09  1.13 0.82 0.94 0.38 
Elastic modulus (kPa) 589 934 917 0.12  529 713 645 0.32 
β-stiffness index 3.43 3.62 3.78 0.07  3.35 3.69 3.53 0.37 
RR for plaque 1.00 0.76 0.47 0.13  1.00 2.67 4.07 0.15 
 Blood MeHg concentration, ng/ml 
Vascular markers 
         
IMT (mm) 0.82 0.78 0.80 0.86  0.74 0.74 0.73 0.79 
Compliance (%/10 mmHg) 1.14 0.65 0.68 0.03  1.06 0.93 0.88 0.13 
Elastic modulus (kPa) 544 1011 895 0.05  564 636 685 0.13 
β-stiffness index 3.32 3.74 3.76 0.02  3.43 3.55 3.60 0.13 
RR for plaque 1.00 0.90 0.36 0.04  1.00 1.50 2.04 0.14 
* Adjusted for age, smoking, physical activity, vegetable, fruit, berry, and oil consumption, salt and alcohol 
intake, and the use of insulin, blood glucose lowering drugs, lipid modifying agents, and antihypertensives 
Abbreviations: IMT, intima-media thickness; MeHg, methylmercury; PCB, polychlorinated biphenyl; PCDD/F, 
polychlorinated dibenzo-p-dioxin and dibenzofuran; TEq, toxic equivalent quantity; RR, risk ratio 
 
Serum PCDD/F+PCB-TEq
 
concentration, pg/g fat: 
a
 men: n=28, mean=36, range 11–67; women: n=30, mean=22, range 7.3–39 
b 
men: n=28, mean=102, range 68–155; women: n=30, mean=54, range 40–74 
c 
men: n=28, mean=234, range 156–590; women: n=30, mean=126, range 75–367 
 
Blood MeHg concentration, ng/ml: 
a 
men: n=27, mean=1.1, range 0.21–2.2; women: n=32, mean=0.92, range 0–1.5 
b 
men: n=30, mean=3.0, range 2.3–3.5; women: n=29, mean=2.0, range 1.6–2.6 
c 
men: n=27, mean=6.2, range 3.6–19; women: n=29, mean=4.4, range 2.7–10 
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Figure. Smoothed associations between log-transformed serum PCDD/F+PCB-TEq concentration or blood 
MeHg concentration and log-transformed HOMA-IR index, log-transformed beta stiffness index, and the risk 
of carotid artery plaque among the Fishermen sub-study men. The figure has been produced by an additive 
model (AM) with a thin-plate regression spline and adjusted for age, smoking, physical activity, vegetable, 
fruit, berry, and oil consumption, salt and alcohol intake, and the use of insulin, blood glucose lowering drugs, 
lipid modifying agents, and antihypertensives. The solid curve is the additive model fit and the dashed curves 
represent the approximate 95% confidence interval. The fit is named as s(log_PCDD/F+PCB-TEq, edf) or 
s(log_MeHg, edf), where edf is the estimated degrees of freedom describing the wiggliness of the fit. The 
plotted points are partial residuals. 
Abbreviations: HOMA, homeostasis model assessment; IR, insulin resistance; MeHg, methylmercury; PCB, 
polychlorinated biphenyl; PCDD/F, polychlorinated dibenzo-p-dioxin and dibenzofuran; TEq, toxic equivalent 
quantity
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Appendix 1 
 
Abbreviations and formulas for the parameters of homeostasis model assessment (HOMA) and ultrasonography  
 
HOMA-IR
a,b
 Insulin resistance index = [serum insulin (mU/l) * serum glucose (mmol/l)] / 22.5 
HOMA-%B
a,b
 β-cell function (%) = [20 x serum insulin (mU/l)] / [serum glucose (mmol/l) - 3.5] 
IMT
a
 Intima-media thickness (mm) = average of three end-diastole CCA IMT measurements 
CAC
a,c
 Carotid artery compliance (%/10 mmHg) 
= ability of the artery to expand according to pulse pressure (elasticity) 
= 100*10*[(ADC/DAD)/PP] 
YEM
a,c
 Young's elastic modulus (kPa) 
= arterial stiffness independent of arterial wall thickness 
= 0.1333*[EP*DAD/(2*IMT)] 
SI
a,c
 β-stiffness index 
= arterial stiffness relatively independent of blood pressure 
=  Ln(SBP/DBP)/(ADC/DAD) 
ADC Arterial diameter change (mm) = SAD–DAD 
DAD Diastolic arterial diameter (mm) = average of three diastolic CCA diameter measurements  
PP Pulse pressure (mmHg) = systolic blood pressure–diastolic blood pressure 
EP
c
 Peterson's elastic modulus (kPa) = 0.1333*(PP*DAD)/ADC 
SAD Systolic arterial diameter (mm) = average of three systolic CCA diameter measurements 
a
 reported in the present work 
b
 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model 
assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in 
man. Diabetologia 1985; 28:412–419. 
c
 Selzer RH, Mack WJ, Lee PL, Kwong-Hu H, Hodis HN. Improved common carotid elasticity and intima-
media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis 2001; 
154:185–193. 
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Appendix 2 
 
Age-adjusted Spearman’s correlation coefficients between fish consumption and serum/blood concentrations of 
fish-derived fatty acids and environmental contaminants in the Health 2000 sub-study and the Fishermen study  
  
 
Spearman correlation coefficients 
 
Fish  
consumption, g/day 
Serum  
omega-3 PUFA 
concentration, % FAs 
Serum  
PCDD/F+PCB-TEq
 
concentration, pg/g fat 
Health 2000 sub-study men (n=532)    
Serum omega-3 PUFA concentration, % FAs 0.35 1 - 
Health 2000 sub-study women (n=641)    
Serum omega-3 PUFA concentration, % FAs 0.29 1 - 
Fishermen sub-study men (n=123)    
Serum omega-3 PUFA concentration, % FAs 0.36 1 1 
Serum PCDD/F+PCB-TEq
 
concentration, pg/g fat 0.47 0.56 1 
Blood MeHg concentration, ng/ml 0.41 0.47 0.59 
Fishermen sub-study women (n=132)    
Serum omega-3 PUFA concentration, % FAs 0.34 1 1 
Serum PCDD/F+PCB-TEq
 
concentration, pg/g fat 0.34 0.18 1 
Blood MeHg concentration, ng/ml 0.44 0.26 0.59 
 
